Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adoptive Transfer of T Regulatory Cell for Suppression of Acute Graft-vs-Host-Disease After an Umbilical Cord Blood Transplant for Hematologic Malignancies

NCT02991898 is registered in ClinicalTrials.gov with Masonic Cancer Center, University of Minnesota as lead sponsor.

NCT NCT02991898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02991898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adoptive Transfer of T Regulatory Cell for Suppression of Acute Graft-vs-Host-Disease After an Umbilical Cord Blood Transplant for Hematologic Malignancies
Lead sponsor
Masonic Cancer Center, University of Minnesota
Phase
Phase 2
Overall status
Terminated
Start date
February 16, 2017
Completion date
June 20, 2019
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, acute myelogenous leukemia, biphenotypic leukemia, burkitt lymphoma, chronic lymphocytic leukemia, chronic myelogenous leukemia, follicular lymphoma, hodgkin lymphoma, large-cell lymphoma, lymphoplasmacytic lymphoma, mantle-cell lymphoma, marginal zone b-cell lymphoma, multiple myeloma, myelodysplastic syndromes, natural killer cell malignancies, prolymphocytic leukemia, small lymphocytic lymphoma, undifferentiated leukemia